Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression

It is now well established that the enzymes phosphoinositide 3-kinases (PI3Ks) have a key role in the development and progression of many cancer types and indeed PI3Ks inhibitors are currently being tested in clinical trials. Although eight distinct PI3K isoforms exist, grouped into three classes, m...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncotarget
Main Authors: Chikh, Anissa, Ferro, Riccardo, Abbott, Jonathan J., Piñeiro, Roberto, Buus, Richard, Iezzi, Manuela, Ricci, Francesca, Bergamaschi, Daniele, Ostano, Paola, Chiorino, Giovanna, Lattanzio, Rossano, Broggini, Massimo, Piantelli, Mauro, Maffucci, Tania, Falasca, Marco
פורמט: Artigo
שפה:Inglês
יצא לאור: Impact Journals LLC 2016
נושאים:
Research Paper
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4951291/
https://ncbi.nlm.nih.gov/pubmed/26934321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7761
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים